GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached copies of newspaper cuttings of the extract of Statement of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021, published in The Financial Express (Mumbai Edition) and on Pudhari (Marathi) dated August 15, 2021. Please acknowledge receipt. GKB Ophthalmics Ltd - 533212 - Intimation Pursuant To Regulation 31A, SEBI ( Listing Obligations And Disclosure Requirements) Regulations , 2015 ( Listing Regulations)
Further to our letter dated August 11, 2021, we wish to inform you that the Board of Directors at its meeting held on August 13, 2021, has considered and approved the requests received from Mr. Krishna Murari Gupta , Mrs. Usha Gupta, Mr. Aditya Gupta and Mr. Vivek Gupta ( 'K.M. Gupta & Family') for reclassification of their shareholding from the 'Promoter and Promoter Group' category to the 'Public' category of shareholders of the Company, in accordance with Regulation 31A, of Listing Regulations. This approval of Board of Directors is subject to the approval of members , Securities and Exchange Board of India, Stock Exchange and other appropriate authorities, as may be necessary. Pursuant to the provisions of Regulation 31A, please find enclosed certified extract of the minutes of the Board of Directors. Kindly take the information on record. GKB Ophthalmics Ltd - 533212 - Revised Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2021
This is with reference to the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2021, submitted with the Exchange on August 13, 2021, at 05.43 PM. In this regard, we are enclosing herewith the revised results, wherein we have corrected the typographical errors. We hereby confirm that there are no changes in the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June, 2021, except the said typographical errors which are mentioned in the enclosed copy. In order to avoid any confusion, we are submitting the whole document i.e Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021, with the above mentioned corrections. We regret the inconvenience caused to the Exchange. We kindly request the Exchange to take on record the enclosed revised Unaudited Standalone and Consolidated Financial results for the quarter ended June 30, 2021. GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations , 2015
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in its meeting held on August 13, 2021, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there was no utilization of funds, during the quarter ended June 30, 2021. Enclosed please find the Statement as per the format, giving details of the same. Kindly take the information on records GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On August 13, 2021.
The meeting of the Board of Directors of the Company was held on August 13, 2021, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2021. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter ended June 30, 2021, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter ended June 30, 2021, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors'' Meeting started at 04:45 P.M. and ended at 05:30 P.M., on the same day. Kindly take the information on record. GKB Ophthalmics Ltd - 533212 - Application For Reclassification Under Regulation 31(A), SEBI ( Listing Obligations And Disclosure Requirements) Regulations , 2015 ( Listing Regulations), From Promoter And Promoter Group Category To Public Category.
This is to inform that we are in receipt of request from Mr. Krishna Murari Gupta , Mrs. Usha Gupta, Mr. Aditya Gupta & Mr. Vivek Gupta ('K.M. Gupta & Family') vide letters dated August 10, 2021, requesting for reclassification of their shareholding from the 'Promoter and Promoter Group' category to the 'Public' category of shareholders of the Company, in accordance with Regulation 31(A), of Listing Regulations. Copy of the request letters is enclosed herewith. The aforesaid request for reclassification from K. M. Gupta & Family will be considered by the Board of Directors in their ensuing meeting and accordingly after considering the merits of the issue will be recommended to the shareholders for their approval pursuant to Regulation 31A of Listing Regulations. Kindly take the information on record. GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Considering And Taking On Record The Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2021.
GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2021. The Notice can be accessed at the Company''s website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors, that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, which has been closed, will now re-open on Monday, August 16, 2021. This communication has been sent to all the Directors and all the designated employees of the Company. GKB OPHTHALMICS LTD. - 533212 - Shareholding for the Period Ended June 30, 2021
GKB Ophthalmics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here GKB OPHTHALMICS LTD. - 533212 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ms Pooja BicholkarDesignation :- Company Secretary and Compliance Officer GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find herewith Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2021. Kindly acknowledge receipt of the same.